CSIMarket
 


Painreform Ltd  (PRFX)
Other Ticker:  
 
 

PRFX's EPS Net Growth by Quarter and Year

Painreform Ltd's EPS Net results by quarter and year




PRFX EPS Net (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December -0.82 -0.74 0.00 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -0.82 -0.74 0.00 0.00



PRFX EPS Net fourth quarter 2022 Y/Y Growth Comment
Painreform Ltd in the fourth quarter 2022 recorded EPS net loss of $ -0.82 .

According to the results reported in the fourth quarter 2022, Painreform Ltd achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Painreform Ltd' s EPS Net no change of % ranks overall at the positon no. in the fourth quarter 2022.




PRFX EPS Net ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Painreform Ltd's fourth quarter 2022 EPS Net $ -0.82 PRFX's Income Statement
Painreform Ltd's fourth quarter 2021 EPS Net $ -0.74 Quarterly PRFX's Income Statement
New: More PRFX's historic EPS Net Growth >>


PRFX EPS Net (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Painreform Ltd's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PRFX's IV. Quarter Q/Q EPS Net Comment


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PRFX's IV. Quarter Q/Q EPS Net Comment


Painreform Ltd's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
0
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
Cumulative EPS Net 12 Months Ending $ -0.82 $ 0.00 $ 0.00 $ 0.00 $ -0.74
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Painreform Ltd' has realized cumulative trailing twelve months EPS net loss of $ -1 in the Dec 31 2022 period.
The results are worsening as the cumulative EPS net loss is becoming larger from $ -0.74 in TTM ending quarter 0 and $ for the twelve months ending in the quarter a year ago.

Painreform Ltd achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Painreform Ltd' has realized cumulative trailing twelve months EPS net loss of $ -1 in the Dec 31 2022 period.
The situation is getting worse as the cumulative EPS net loss is becoming larger from $ -0.74 in TTM ending quarter 0 and $ from the TTM period ending Dec 31 2021.

Painreform Ltd achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
PRFX's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for PRFX's Competitors
EPS Net Growth for Painreform Ltd's Suppliers
EPS Net Growth for PRFX's Customers

You may also want to know
PRFX's Annual Growth Rates PRFX's Profitability Ratios PRFX's Asset Turnover Ratio PRFX's Dividend Growth
PRFX's Roe PRFX's Valuation Ratios PRFX's Financial Strength Ratios PRFX's Dividend Payout Ratio
PRFX's Roa PRFX's Inventory Turnover Ratio PRFX's Growth Rates PRFX's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Dec 31 2022
Cyclacel Pharmaceuticals Inc 18.18%$ 18.182 
Conmed Corporation17.19%$ 17.186 
Zoetis Inc 13.77%$ 13.769 
Eli Lilly And Company13.61%$ 13.613 
Utah Medical Products Inc11.81%$ 11.810 
Resmed Inc 11.68%$ 11.679 
United Therapeutics Corporation11.45%$ 11.454 
Addus Homecare Corporation10.51%$ 10.512 
Halozyme Therapeutics Inc 10.04%$ 10.044 
Electromed Inc 10.00%$ 10.000 
Idexx Laboratories Inc10.00%$ 9.999 
Zynex inc 6.74%$ 6.742 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com